Abstract

Phytoestrogen has been proposed as an alternative to hormone replacement therapy, which has been demonstrated to promote a high risk of breast cancer. However, the effect of phytoestrogen on breast cancer development has not been fully understood. Bakuchiol is an active ingredient of a traditional Chinese herbal medicine Fructus Psoraleae, the dried ripe fruit of Psoralea corylifolia L. (Fabaceae). The in vitro and in vivo estrogenic activities and anti-breast cancer effects of bakuchiol have not been well-studied. We found that bakuchiol induced the GFP expression in transgenic medaka (Oryzias melastigma, Tg, Chg:GFP) dose-dependently (0–1 μg/ml), demonstrating its in vivo estrogenic activity. Low dose of bakuchiol (1 μg/ml) induced the cell proliferation and ERα expression in MCF-7 cells, which could be blocked by the anti-estrogen ICI 182780, suggesting the in vitro estrogenic activity of bakuchiol. Our data indicated that high doses of bakuchiol (>2 μg/ml) inhibited breast cancer cell growth, with a stronger anti-proliferative effect than resveratrol, a widely studied analog of bakuchiol. High doses of bakuchiol (4, 7, and 10 μg/ml) were used for the further in vitro anti-breast cancer studies. Bakuchiol induced ERβ expression and suppressed ERα expression in MCF-7 cells. It also induced S phase arrest in both MCF-7 and MDA-MB-231 cells, which could be rescued by caffeine. Knock-down of p21 also marginally rescued S phase arrest in MCF-7 cells. The S phase arrest was accompanied by the upregulation of ATM, P-Cdc2 (Tyr15), Myt1, P-Wee1 (Ser642), p21 and Cyclin B1, suggesting that blocking of Cdc2 activation may play an important role in bakuchiol-induced S phase arrest. Furthermore, bakuchiol induced cell apoptosis and disturbed mitochondrial membrane potential in MCF-7 cells. The bakuchiol-induced apoptosis was associated with increased expression of Caspase family and Bcl-2 family proteins, suggesting that bakuchiol may induce apoptosis via intrinsic apoptotic pathway. The in vivo anti-breast cancer effect of bakuchiol was further proved in zebrafish (Danio rerio, wild-type AB) xenografts. 0.5 μg/ml of bakuchiol significantly reduced the MCF-7 cell mass in zebrafish xenografts. Overall, these results suggested the potential of using bakuchiol in HRT and breast cancer treatment.

Highlights

  • According to the statistics released by the International Agency for Research on Cancer (2013)1, 1.7 million women were diagnosed with breast cancer, which killed more than 0.5 million women in 2012

  • The green fluorescent protein (GFP) intensity of the effective concentration 50 (EC50) (0.3 μg/ml) of bakuchiol was comparable to the estrogenicity of 1.6 ppb (∼1.6 μg/l) E2

  • The results suggested that bakuchiol is a weak estrogen; about 180 times weaker than E2

Read more

Summary

Introduction

According to the statistics released by the International Agency for Research on Cancer (2013)1, 1.7 million women were diagnosed with breast cancer, which killed more than 0.5 million women in 2012. Breast cancer incidence in developed countries of North America and Western Europe is historically higher than in Asian countries, which has been associated to the higher intake of phytoestrogens in the eastern continent (de Kleijn et al, 2001). It has been demonstrated that estrogen, which is used in HRT, increases the risk of breast cancer development (Key et al, 2001). Women, mainly those with a history of breast cancer, are turning to the use of phytoestrogens, in the belief that they protect them from breast cancer and they are safer than estrogen itself

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call